Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v8-FR | Version v3-EN | |
---|---|---|
Language | French | English |
Date Updated | 2018-04-13 | 2018-03-16 |
Drug Identification Number | 02188880 | 02188880 |
Brand name | BREVIBLOC INJECTION 10MG/ML | BREVIBLOC INJECTION 10MG/ML |
Common or Proper name | Brevibloc Injection | Brevibloc Injection |
Company Name | BAXTER CORPORATION | BAXTER CORPORATION |
Ingredients | ESMOLOL HYDROCHLORIDE | ESMOLOL HYDROCHLORIDE |
Strength(s) | 10MG | 10MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | INTRAVENOUS | INTRAVENOUS |
Packaging size | 10mL vials | 10mL vials |
ATC code | C07AB | C07AB |
ATC description | BETA BLOCKING AGENTS | BETA BLOCKING AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-03-09 | 2018-03-09 |
Actual start date | 2018-03-27 | 2018-03-09 |
Estimated end date | 2018-05-04 | 2018-04-20 |
Actual end date | ||
Shortage status | Actual shortage | Actual shortage |
Tier 3 Status | No | No |
Company comments | For further questions regarding this product, please contact Baxter Customer Service at 1-888-719-9955 or Medical Information at 1-855-584-1368. | For further questions regarding this product, please contact Baxter Customer Service at 1-888-719-9955 or Medical Information at 1-855-584-1368. |
Health Canada comments |